This activity is supported by an unrestricted educational grant from Aerie Pharmaceuticals.
Upon completion of this activity, the participant should be able to:
• Describe the mechanisms of action of novel therapeutics and classes of drugs
• Compare the efficacy of novel therapeutics with traditional prostaglandins
• Understand and explain the likelihood of achieving target intraocular pressure with monotherapy compared with combination regimens
• Restate the most common side effects of novel therapeutics
• Identify how to provide the best possible collaborative care when comanaging patients
PROVIDED BY Evolve Medical Education LLC
ACCREDITATION STATEMENT
Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
Evolve designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Sponsored by: 
Evolve is an approved COPE administrator.
This course is COPE approved for 1.0 hour of CE credit for optometrists.
Course Number: 69218-GL
Activity Number: 120056
TO OBTAIN CREDIT
To obtain credit for this activity, you must read the activity in its entirety and complete the Pretest/Posttest/Activity Evaluation/Satisfaction Measures Form, which consists of a series of multiple-choice questions.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS
Hardware Requirements:
4GB+ RAM
Recommended internet speed 5Mbps+
Gagan Sawhney, MD
Moderator
Glaucoma Specialist
Georgia Eye Partners
Atlanta, GA
Jacob W. Brubaker, MD
Glaucoma Specialist
Sacramento Eye Consultants
Sacramento, CA
Ian Benjamin Gaddie, OD
Chief Medical Officer
Kelper Vision Partner
Gaddie Eye Centers
Louisville, KY
Oluwatosin U. Smith, MD
Glaucoma Specialist
Glaucoma Associates of Texas
Dallas, TX
DISCLOSURES
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Gagan Sawhney, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie Pharmaceuticals, Allergan, and New World Medical.
Jacob W. Brubaker, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie Pharmaceuticals, Allergan, Glaukos, Ivantis, and New World Medical. Grant/Research Support: Aerie Pharmaceuticals, Allergan, Equinox, Glaukos, Ivantis, Nicox and Santen. Speakers Bureau: Aerie Pharmaceuticals and Allergan.
Ian Benjamin Gaddie, OD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant and Speaker’s Bureau: Aerie Pharmaceuticals, Allergan, Bausch + Lomb, Ivantis, Novartis, and Sight Sciences. Grant/Research Support: Aerie Pharmaceuticals. Stock/Shareholder: Leo Lens and Tarsus.
Oluwatosin U. Smith, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie Pharmaceuticals, Allergan, Glaukos, Iridex, and New World Medical. Grant/Research Support: Allergan, Glaukos, and Santen. Speaker’s Bureau: Aerie Pharmaceuticals, Allergan, and Bausch + Lomb.
EDITORIAL SUPPORT DISCLOSURES
The Evolve staff and planners have no financial relationships with commercial interests. Michelle Dalton, writer, and Nisha Mukherjee, MD, peer reviewer, have no financial relationships with commercial interests.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Glaucoma Today, Modern Optometry, or Aerie Pharmaceuticals.
